Recombinant gland-related virus AAV-gas6 and application
A technology of aav-gas6 and virus, applied in the direction of recombinant DNA technology, virus, application, etc., can solve the problems of JE patients without specific and effective means, and achieve the effect of enhancing integrity, maintaining steady state, and stable expression
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0023] Construction of recombinant adeno-associated virus AAV-gas6
[0024] 1. Determine the CDS region of the mouse gas6 gene sequence;
[0025] 2. Extract total RNA from mouse brain tissue, reverse transcribe it into cDNA as template DNA, design and synthesize the upstream and downstream primers of the gas6 gene coding region (as shown in SEQ ID NO: 2-3), and introduce restriction enzymes Restriction site BglⅡ and xhoⅠ, PCR amplification to obtain mouse gas6 expression gene, namely the nucleic acid sequence shown in SEQ ID NO: 1;
[0026] The PCR amplification system is: template DNA 1 μL, upstream primer: 1 μL, downstream primer R: 1 μL, dNTP: 2 μL, Q5 ultra-fidelity DNA polymerase: 0.5 μL, Buffer: 2 μL, ddH2O: 12.5 μL;
[0027] The amplification program is: 98°C for 30s; 98°C for 10s, 63°C for 15s, 72°C for 60s, a total of 30 cycles; 72°C for 2min; 4°C hold. PCR products were subjected to 1% nucleic acid electrophoresis, and the target band was recovered from the gel.
...
Embodiment 2
[0032] Recombinant adeno-associated virus AAV-gas6 intracerebroventricular injection and virus challenge verification
[0033] 1. The prepared AAV-gas6 virus is used for intracerebroventricular injection after verification of in vitro cell infection experiments.
[0034]2. Mice were 3-4 weeks old, using a stereotaxic instrument and a microinjector, and the injection site: 0.6mm behind the bregma site, 1.2mm next to the midline, and 2.3mm under the dura mater, using a microinjection injection volume of 4 μl (experimental group AAV-gas6, control group AAV-GFP), slow injection, about 5min / time. At 1, 2, and 3 weeks after injection, gas6 in the brain tissue of each group was collected to detect changes in the expression of gas6 in the brain tissue. At the 4th week after the intracerebroventricular injection, different virus doses were used to challenge the plantar injection of JEV, and the survival rate of the mice in each group was recorded.
[0035] The result is as Figure 1...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com